Antibody validation: a view from the mountains

Michael J. Taussig, Cláudia Fonseca, James Trimmer

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Validation of antibodies and other protein binders is a subject of pressing concern for the research community and one which is uppermost in the minds of all who use antibodies as research and diagnostic reagents. Assessing an antibody's fitness for purpose includes accurate ascertainment of its target specificity and suitability for the envisaged task. Moreover, standardised procedures are essential to guarantee sample quality in testing procedures. The problem of defining precise standards for antibody validation has engendered much debate in recent publications and meetings, but gradually a consensus is emerging. At the 8th Alpbach Affinity Proteomics workshop (March 2017), a panel of leaders in the antibody field discussed suggestions which could bring this complex but essential issue a step nearer to a resolution. ‘Alpbach recommendations’ for best practice include tailoring binder validation processes according to the intended applications and promoting greater transparency in publications and in the information available from commercial antibody developers/providers. A single approach will not fit all applications and end users must ensure that the reported validation holds for their specific requirements, highlighting the need for adequate training in the fundamentals of antibody characterisation and validation across the user community.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalNew Biotechnology
Volume45
DOIs
StatePublished - Oct 25 2018

Fingerprint

Antibodies
Binders
Practice Guidelines
Research
Proteomics
Transparency
Publications
Proteins
Education
Testing

Keywords

  • Affinity proteomics
  • Alpbach workshop
  • Antibody characterization
  • Antibody validation
  • Antibody validation guidelines
  • Pre-analytics

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Molecular Biology

Cite this

Antibody validation : a view from the mountains. / Taussig, Michael J.; Fonseca, Cláudia; Trimmer, James.

In: New Biotechnology, Vol. 45, 25.10.2018, p. 1-8.

Research output: Contribution to journalReview article

Taussig, Michael J. ; Fonseca, Cláudia ; Trimmer, James. / Antibody validation : a view from the mountains. In: New Biotechnology. 2018 ; Vol. 45. pp. 1-8.
@article{cc6fa878b8a4471dac08d63484a2ed4e,
title = "Antibody validation: a view from the mountains",
abstract = "Validation of antibodies and other protein binders is a subject of pressing concern for the research community and one which is uppermost in the minds of all who use antibodies as research and diagnostic reagents. Assessing an antibody's fitness for purpose includes accurate ascertainment of its target specificity and suitability for the envisaged task. Moreover, standardised procedures are essential to guarantee sample quality in testing procedures. The problem of defining precise standards for antibody validation has engendered much debate in recent publications and meetings, but gradually a consensus is emerging. At the 8th Alpbach Affinity Proteomics workshop (March 2017), a panel of leaders in the antibody field discussed suggestions which could bring this complex but essential issue a step nearer to a resolution. ‘Alpbach recommendations’ for best practice include tailoring binder validation processes according to the intended applications and promoting greater transparency in publications and in the information available from commercial antibody developers/providers. A single approach will not fit all applications and end users must ensure that the reported validation holds for their specific requirements, highlighting the need for adequate training in the fundamentals of antibody characterisation and validation across the user community.",
keywords = "Affinity proteomics, Alpbach workshop, Antibody characterization, Antibody validation, Antibody validation guidelines, Pre-analytics",
author = "Taussig, {Michael J.} and Cl{\'a}udia Fonseca and James Trimmer",
year = "2018",
month = "10",
day = "25",
doi = "10.1016/j.nbt.2018.08.002",
language = "English (US)",
volume = "45",
pages = "1--8",
journal = "New Biotechnology",
issn = "1871-6784",
publisher = "Elsevier",

}

TY - JOUR

T1 - Antibody validation

T2 - a view from the mountains

AU - Taussig, Michael J.

AU - Fonseca, Cláudia

AU - Trimmer, James

PY - 2018/10/25

Y1 - 2018/10/25

N2 - Validation of antibodies and other protein binders is a subject of pressing concern for the research community and one which is uppermost in the minds of all who use antibodies as research and diagnostic reagents. Assessing an antibody's fitness for purpose includes accurate ascertainment of its target specificity and suitability for the envisaged task. Moreover, standardised procedures are essential to guarantee sample quality in testing procedures. The problem of defining precise standards for antibody validation has engendered much debate in recent publications and meetings, but gradually a consensus is emerging. At the 8th Alpbach Affinity Proteomics workshop (March 2017), a panel of leaders in the antibody field discussed suggestions which could bring this complex but essential issue a step nearer to a resolution. ‘Alpbach recommendations’ for best practice include tailoring binder validation processes according to the intended applications and promoting greater transparency in publications and in the information available from commercial antibody developers/providers. A single approach will not fit all applications and end users must ensure that the reported validation holds for their specific requirements, highlighting the need for adequate training in the fundamentals of antibody characterisation and validation across the user community.

AB - Validation of antibodies and other protein binders is a subject of pressing concern for the research community and one which is uppermost in the minds of all who use antibodies as research and diagnostic reagents. Assessing an antibody's fitness for purpose includes accurate ascertainment of its target specificity and suitability for the envisaged task. Moreover, standardised procedures are essential to guarantee sample quality in testing procedures. The problem of defining precise standards for antibody validation has engendered much debate in recent publications and meetings, but gradually a consensus is emerging. At the 8th Alpbach Affinity Proteomics workshop (March 2017), a panel of leaders in the antibody field discussed suggestions which could bring this complex but essential issue a step nearer to a resolution. ‘Alpbach recommendations’ for best practice include tailoring binder validation processes according to the intended applications and promoting greater transparency in publications and in the information available from commercial antibody developers/providers. A single approach will not fit all applications and end users must ensure that the reported validation holds for their specific requirements, highlighting the need for adequate training in the fundamentals of antibody characterisation and validation across the user community.

KW - Affinity proteomics

KW - Alpbach workshop

KW - Antibody characterization

KW - Antibody validation

KW - Antibody validation guidelines

KW - Pre-analytics

UR - http://www.scopus.com/inward/record.url?scp=85051248232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051248232&partnerID=8YFLogxK

U2 - 10.1016/j.nbt.2018.08.002

DO - 10.1016/j.nbt.2018.08.002

M3 - Review article

C2 - 30086383

AN - SCOPUS:85051248232

VL - 45

SP - 1

EP - 8

JO - New Biotechnology

JF - New Biotechnology

SN - 1871-6784

ER -